Boehringer Loses Bid To Decertify Sales Rep OT Action
A Connecticut federal judge on Tuesday declined Boehringer Ingelheim Pharmaceuticals Inc.'s attempt to decertify a collective action alleging the drugmaker failed to properly compensate its drug sales representatives for overtime....To view the full article, register now.
Already a subscriber? Click here to view full article